ArticleCell reports. Medicine2025

Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety.

Michael E Barish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.